MPR Weekly Dose 79 - COVID-19: vaccine storage, efficacy updates; Gene therapy Fast Tracked; Vitiligo cream trial results; Aspirin dosage compared in ASCVD episode artwork

EPISODE · May 21, 2021 · 9 MIN

MPR Weekly Dose 79 - COVID-19: vaccine storage, efficacy updates; Gene therapy Fast Tracked; Vitiligo cream trial results; Aspirin dosage compared in ASCVD

from MPR Weekly Dose

This week we have news of a change to the storage of the Pfizer-BioNTech vaccine; A gene therapy gets Fast Track status by the FDA; Vitiligo cream shows promise in clinical trials; And outcomes in atherosclerotic cardiovascular disease are compared for different aspirin dosages.

Episode metadata supplied by the publisher feed · Published May 21, 2021

Embed this episode

Ready to play

MPR Weekly Dose 79 - COVID-19: vaccine storage, efficacy updates; Gene therapy Fast Tracked; Vitiligo cream trial results; Aspirin dosage compared in ASCVD

0:00 9:18

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MPR Weekly Dose?

This episode is 9 minutes long.

When was this MPR Weekly Dose episode published?

This episode was published on May 21, 2021.

Can I download this MPR Weekly Dose episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!